345504 <common-name>[(3r,4as,5r,6r,6ar,10r,10as,10br)-3-ethenyl-5,10,10b-trihydroxy-2,4a,7,7,10a-pentamethyl-1-oxo-2,3,5,6,6a,8,9,10-octahydrobenzo[f]chromen-6-yl] 2-morpholin-4-ylacetate</common-name> <description>[(3r,4as,5r,6r,6ar,10r,10as,10br)-3-ethenyl-5,10,10b-trihydroxy-2,4a,7,7,10a-pentamethyl-1-oxo-2,3,5,6,6a,8,9,10-octahydrobenzo[f]chromen-6-yl] 2-morpholin-4-ylacetate is a compound with the formula C26H41NO8. It has an average molecular weight of 495.60 g/mol.</description> <cas nil="true"/> <pubchem-id>3066776</pubchem-id> <chemical-formula>C26H41NO8</chemical-formula> <weight>495.6</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-08-31T08:17:58Z</created-at> <updated-at type="dateTime">2026-08-31T08:17:58Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>CC1C(OC2(C(C(C3C(CCC(C3(C2(C1=O)O)C)O)(C)C)OC(=O)CN4CCOCC4)O)C)C=C</moldb-smiles> <moldb-formula>C26H41NO8</moldb-formula> <moldb-inchi>InChI=1S/C26H41NO8/c1-7-16-15(2)21(30)26(32)24(5)17(28)8-9-23(3,4)20(24)19(22(31)25(26,6)35-16)34-18(29)14-27-10-12-33-13-11-27/h7,15-17,19-20,22,28,31-32H,1,8-14H2,2-6H3/t15?,16-,17-,19-,20-,22-,24-,25+,26-/m1/s1</moldb-inchi> <moldb-inchikey>KOHLVKZCVZOQOP-FGNNVXJKSA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">495.2832173</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>1.1</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM341397</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>[(3r,4as,5r,6r,6ar,10r,10as,10br)-3-ethenyl-5,10,10b-trihydroxy-2,4a,7,7,10a-pentamethyl-1-oxo-2,3,5,6,6a,8,9,10-octahydrobenzo[f]chromen-6-yl] 2-morpholin-4-ylacetate</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Organoheterocyclic compounds</superklass> <klass>Naphthopyrans</klass> <subklass nil="true"/> <paper-count type="integer" nil="true"/> <sync-id>CED0295861</sync-id> <structure-inchikey>KOHLVKZCVZOQOP-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>4000000000000000000880000000000000000010000000008000001400000000200040000000020000000000000000000000002000002000000804000000000001000000000000000008000000000400020800000000300000000040000008080000000090000000000000000000000000000020108220000000000000000100000000048020100000000000200000020200000000000000000800000400020000000048004000000000200082000040000000040000000018000000000001000001000000000000000400000040000100000000000000000000000000000010000080000000040000000000000000400000802000000000000000000000000</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAjAAAAJgAAAIABBgBgAAAAAQMGAGAAAAAD AQYAYAAAAAMBCAAgAAAAAgYAIAAAAAQGAGAAAAADAQYAYAAAAAMBBgBgAAAA AwEGACAAAAAEBgBgAAAAAgIGAGAAAAACAgYAYAAAAAMBBgAgAAAABAYAIAAA AAQGACgAAAADBAgAKAAAAAMCCABgAAAAAQEGAGAAAAABAwgAYAAAAAEBBgBg AAAAAQMGAGAAAAABAwgAKAAAAAMCBgAoAAAAAwQIACgAAAADAgYAYAAAAAIC BwAgAAAAAwYAYAAAAAICBgBgAAAAAgIIACAAAAACBgBgAAAAAgIGAGAAAAAC AggAYAAAAAEBBgBgAAAAAQMGAGgAAAADAwEGAGgAAAADAgILAAEAAQIAAgMA AwQABAUABQYABgcABwgACAkACQoACgsACwwADA0ADQ4ADg8IAg0QAAwRAAsS AAgTAAgUAAYVABUWIBYXKAIWGAAYGQAZGgAaGwAbHAAcHQAdHgAFHwAEIAAC IQAhIggCDgEADQQADAcAHhkAQgQAAAAGAQ4NBAMCBgUGBwwNBAYICQoLDAcG GhscHR4ZFwQAAAAAAAAAFg== </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:44:32Z</structure-indexed-at> </compound>